Cargando…

Long-Term Survival in HIV Positive Patients with up to 15 Years of Antiretroviral Therapy

BACKGROUND: Life expectancy has increased for newly diagnosed HIV patients since the inception of combination antiretroviral treatment (cART), but there remains a need to better understand the characteristics of long-term survival in HIV-positive patients. We examined long-term survival in HIV-posit...

Descripción completa

Detalles Bibliográficos
Autores principales: McManus, Hamish, O'Connor, Catherine C., Boyd, Mark, Broom, Jennifer, Russell, Darren, Watson, Kerrie, Roth, Norman, Read, Phillip J., Petoumenos, Kathy, Law, Matthew G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492258/
https://www.ncbi.nlm.nih.gov/pubmed/23144991
http://dx.doi.org/10.1371/journal.pone.0048839
_version_ 1782249093967380480
author McManus, Hamish
O'Connor, Catherine C.
Boyd, Mark
Broom, Jennifer
Russell, Darren
Watson, Kerrie
Roth, Norman
Read, Phillip J.
Petoumenos, Kathy
Law, Matthew G.
author_facet McManus, Hamish
O'Connor, Catherine C.
Boyd, Mark
Broom, Jennifer
Russell, Darren
Watson, Kerrie
Roth, Norman
Read, Phillip J.
Petoumenos, Kathy
Law, Matthew G.
author_sort McManus, Hamish
collection PubMed
description BACKGROUND: Life expectancy has increased for newly diagnosed HIV patients since the inception of combination antiretroviral treatment (cART), but there remains a need to better understand the characteristics of long-term survival in HIV-positive patients. We examined long-term survival in HIV-positive patients receiving cART in the Australian HIV Observational Database (AHOD), to describe changes in mortality compared to the general population and to develop longer-term survival models. METHODS: Data were examined from 2,675 HIV-positive participants in AHOD who started cART. Standardised mortality ratios (SMR) were calculated by age, sex and calendar year across prognostic characteristics using Australian Bureau of Statistics national data as reference. SMRs were examined by years of duration of cART by CD4 and similarly by viral load. Survival was analysed using Cox-proportional hazards and parametric survival models. RESULTS: The overall SMR for all-cause mortality was 3.5 (95% CI: 3.0–4.0). SMRs by CD4 count were 8.6 (95% CI: 7.2–10.2) for CD4<350 cells/µl; 2.1 (95% CI: 1.5–2.9) for CD4 = 350–499 cells/µl; and 1.5 (95% CI: 1.1–2.0) for CD4≥500 cells/µl. SMRs for patients with CD4 counts <350 cells/µL were much higher than for patients with higher CD4 counts across all durations of cART. SMRs for patients with viral loads greater than 400 copies/ml were much higher across all durations of cART. Multivariate models demonstrated improved survival associated with increased recent CD4, reduced recent viral load, younger patients, absence of HBVsAg-positive ever, year of HIV diagnosis and incidence of ADI. Parametric models showed a fairly constant mortality risk by year of cART up to 15 years of treatment. CONCLUSION: Observed mortality remained fairly constant by duration of cART and was modelled accurately by accepted prognostic factors. These rates did not vary much by duration of treatment. Changes in mortality with age were similar to those in the Australian general population.
format Online
Article
Text
id pubmed-3492258
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-34922582012-11-09 Long-Term Survival in HIV Positive Patients with up to 15 Years of Antiretroviral Therapy McManus, Hamish O'Connor, Catherine C. Boyd, Mark Broom, Jennifer Russell, Darren Watson, Kerrie Roth, Norman Read, Phillip J. Petoumenos, Kathy Law, Matthew G. PLoS One Research Article BACKGROUND: Life expectancy has increased for newly diagnosed HIV patients since the inception of combination antiretroviral treatment (cART), but there remains a need to better understand the characteristics of long-term survival in HIV-positive patients. We examined long-term survival in HIV-positive patients receiving cART in the Australian HIV Observational Database (AHOD), to describe changes in mortality compared to the general population and to develop longer-term survival models. METHODS: Data were examined from 2,675 HIV-positive participants in AHOD who started cART. Standardised mortality ratios (SMR) were calculated by age, sex and calendar year across prognostic characteristics using Australian Bureau of Statistics national data as reference. SMRs were examined by years of duration of cART by CD4 and similarly by viral load. Survival was analysed using Cox-proportional hazards and parametric survival models. RESULTS: The overall SMR for all-cause mortality was 3.5 (95% CI: 3.0–4.0). SMRs by CD4 count were 8.6 (95% CI: 7.2–10.2) for CD4<350 cells/µl; 2.1 (95% CI: 1.5–2.9) for CD4 = 350–499 cells/µl; and 1.5 (95% CI: 1.1–2.0) for CD4≥500 cells/µl. SMRs for patients with CD4 counts <350 cells/µL were much higher than for patients with higher CD4 counts across all durations of cART. SMRs for patients with viral loads greater than 400 copies/ml were much higher across all durations of cART. Multivariate models demonstrated improved survival associated with increased recent CD4, reduced recent viral load, younger patients, absence of HBVsAg-positive ever, year of HIV diagnosis and incidence of ADI. Parametric models showed a fairly constant mortality risk by year of cART up to 15 years of treatment. CONCLUSION: Observed mortality remained fairly constant by duration of cART and was modelled accurately by accepted prognostic factors. These rates did not vary much by duration of treatment. Changes in mortality with age were similar to those in the Australian general population. Public Library of Science 2012-11-07 /pmc/articles/PMC3492258/ /pubmed/23144991 http://dx.doi.org/10.1371/journal.pone.0048839 Text en © 2012 McManus et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
McManus, Hamish
O'Connor, Catherine C.
Boyd, Mark
Broom, Jennifer
Russell, Darren
Watson, Kerrie
Roth, Norman
Read, Phillip J.
Petoumenos, Kathy
Law, Matthew G.
Long-Term Survival in HIV Positive Patients with up to 15 Years of Antiretroviral Therapy
title Long-Term Survival in HIV Positive Patients with up to 15 Years of Antiretroviral Therapy
title_full Long-Term Survival in HIV Positive Patients with up to 15 Years of Antiretroviral Therapy
title_fullStr Long-Term Survival in HIV Positive Patients with up to 15 Years of Antiretroviral Therapy
title_full_unstemmed Long-Term Survival in HIV Positive Patients with up to 15 Years of Antiretroviral Therapy
title_short Long-Term Survival in HIV Positive Patients with up to 15 Years of Antiretroviral Therapy
title_sort long-term survival in hiv positive patients with up to 15 years of antiretroviral therapy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492258/
https://www.ncbi.nlm.nih.gov/pubmed/23144991
http://dx.doi.org/10.1371/journal.pone.0048839
work_keys_str_mv AT mcmanushamish longtermsurvivalinhivpositivepatientswithupto15yearsofantiretroviraltherapy
AT oconnorcatherinec longtermsurvivalinhivpositivepatientswithupto15yearsofantiretroviraltherapy
AT boydmark longtermsurvivalinhivpositivepatientswithupto15yearsofantiretroviraltherapy
AT broomjennifer longtermsurvivalinhivpositivepatientswithupto15yearsofantiretroviraltherapy
AT russelldarren longtermsurvivalinhivpositivepatientswithupto15yearsofantiretroviraltherapy
AT watsonkerrie longtermsurvivalinhivpositivepatientswithupto15yearsofantiretroviraltherapy
AT rothnorman longtermsurvivalinhivpositivepatientswithupto15yearsofantiretroviraltherapy
AT readphillipj longtermsurvivalinhivpositivepatientswithupto15yearsofantiretroviraltherapy
AT petoumenoskathy longtermsurvivalinhivpositivepatientswithupto15yearsofantiretroviraltherapy
AT lawmatthewg longtermsurvivalinhivpositivepatientswithupto15yearsofantiretroviraltherapy
AT longtermsurvivalinhivpositivepatientswithupto15yearsofantiretroviraltherapy